Funder
Pfizer
Cedars-Sinai Medical Center
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference19 articles.
1. National Cancer Institute. SEER Cancer Stat Facts: Prostate Cancer. 2022. https://seer.cancer.gov/statfacts/html/prost.html. Accessed 8 Aug 2022.
2. Kupelian PA, Mahadevan A, Reddy CA, Reuther AM, Klein EA. Use of different definitions of biochemical failure after external beam radiotherapy changes conclusions about relative treatment efficacy for localized prostate cancer. Urology. 2006;68(3):593–8. https://doi.org/10.1016/j.urology.2006.03.075.
3. Francini E, Gray KP, Xie W, Shaw GK, Valença L, Bernard B, et al. Time of metastatic disease presentation and volume of disease are prognostic for metastatic hormone sensitive prostate cancer (mHSPC). Prostate. 2018;78(12):889–95. https://doi.org/10.1002/pros.23645.
4. Lowrance WT, Breau RH, Chou R, Chapin BF, Crispino T, Dreicer R, et al. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. J Urol. 2021;205(1):22–9. https://doi.org/10.1097/JU.0000000000001376.
5. US Food and Drug Administration. Pluvicto (lutetium-177) FDA Prescribing Information, Novartis AG. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215833s000lbl.pdf. Accessed 26 Sep 2022.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献